SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-422978"
 

Search: onr:"swepub:oai:DiVA.org:uu-422978" > CombiANT :

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Fatsis-Kavalopoulos, NikosUppsala universitet,Institutionen för medicinsk cellbiologi (author)

CombiANT : Antibiotic interaction testing made easy

  • Article/chapterEnglish2020

Publisher, publication year, extent ...

  • 2020-09-17
  • PUBLIC LIBRARY SCIENCE,2020
  • electronicrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-422978
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-422978URI
  • https://doi.org/10.1371/journal.pbio.3000856DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Antibiotic combination therapies are important for the efficient treatment of many types of infections, including those caused by antibiotic-resistant pathogens. Combination treatment strategies are typically used under the assumption that synergies are conserved across species and strains, even though recent results show that the combined treatment effect is determined by specific drug-strain interactions that can vary extensively and unpredictably, both between and within bacterial species. To address this problem, we present a new method in which antibiotic synergy is rapidly quantified on a case-by-case basis, allowing for improved combination therapy. The novel CombiANT methodology consists of a 3D-printed agar plate insert that produces defined diffusion landscapes of 3 antibiotics, permitting synergy quantification between all 3 antibiotic pairs with a single test. Automated image analysis yields fractional inhibitory concentration indices (FICis) with high accuracy and precision. A technical validation with 3 major pathogens,Escherichia coli,Pseudomonas aeruginosa, andStaphylococcus aureus, showed equivalent performance to checkerboard methodology, with the advantage of strongly reduced assay complexity and costs for CombiANT. A synergy screening of 10 antibiotic combinations for 12E.coliurinary tract infection (UTI) clinical isolates illustrates the need for refined combination treatment strategies. For example, combinations of trimethoprim (TMP) + nitrofurantoin (NIT) and TMP + mecillinam (MEC) showed synergy, but only for certain individual isolates, whereas MEC + NIT combinations showed antagonistic interactions across all tested strains. These data suggest that the CombiANT methodology could allow personalized clinical synergy testing and large-scale screening. We anticipate that CombiANT will greatly facilitate clinical and basic research of antibiotic synergy.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Römhild, RoderichUppsala universitet,Institutionen för medicinsk biokemi och mikrobiologi(Swepub:uu)rodro273 (author)
  • Tang, Po-ChengUppsala universitet,Institutionen för medicinsk biokemi och mikrobiologi,Institutionen för medicinsk cellbiologi(Swepub:uu)pocta879 (author)
  • Kreuger, Johan,1972-Uppsala universitet,Institutionen för medicinsk cellbiologi(Swepub:uu)jkr07842 (author)
  • Andersson, Dan IUppsala universitet,Institutionen för medicinsk biokemi och mikrobiologi(Swepub:uu)dan19789 (author)
  • Uppsala universitetInstitutionen för medicinsk cellbiologi (creator_code:org_t)

Related titles

  • In:PLoS biology: PUBLIC LIBRARY SCIENCE18:91544-91731545-7885

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Find more in SwePub

By the author/editor
Fatsis-Kavalopou ...
Römhild, Roderic ...
Tang, Po-Cheng
Kreuger, Johan, ...
Andersson, Dan I
About the subject
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Clinical Medicin ...
and Infectious Medic ...
Articles in the publication
PLoS biology
By the university
Uppsala University

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view